Equity Overview
Price & Market Data
Price: $0.30
Daily Change: +$0.006 / 2.00%
Range: $0.294 - $0.30
Market Cap: $23,427,448
Volume: 2,613
Performance Metrics
1 Week: 1.17%
1 Month: -4.05%
3 Months: -17.18%
6 Months: -24.71%
1 Year: -40.00%
YTD: -12.50%
Company Details
Employees: 67
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.